Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-09-23 5:42 pm Purchase | 2024-09-12 | 13G | Praxis Precision Medicines, Inc. PRAX | PERCEPTIVE ADVISORS LLC | 1,119,035 6.300% | 1,119,035 (New Position) | Filing History |
| 2024-08-15 6:31 pm Sale | 2024-08-14 | 13D | Lyra Therapeutics, Inc. LYRA | PERCEPTIVE ADVISORS LLC | 12,757,562 19.500% | -1 (-0.00%) | Filing History |
| 2024-08-14 7:21 pm Purchase | 2024-08-12 | 13D | MeiraGTx Holdings plc MGTX | PERCEPTIVE ADVISORS LLC | 12,696,562 16.400% | 1,254,000 (+10.96%) | Filing History |
| 2024-07-29 9:43 pm Purchase | 2024-07-17 | 13G | Verona Pharma plc VRNA | PERCEPTIVE ADVISORS LLC | 5,118,145 6.300% | 1,251,931 (+32.38%) | Filing History |
| 2024-07-17 4:32 pm Purchase | 2024-07-11 | 13G | Orchestra BioMed Holdings, Inc. OBIO | PERCEPTIVE ADVISORS LLC | 4,592,556 12.800% | 2,160,467 (+88.83%) | Filing History |
| 2024-06-25 8:16 pm Purchase | 2024-06-17 | 13D | Vapotherm, Inc. VAPO | PERCEPTIVE ADVISORS LLC | 2,012,999 32.400% | 2,012,999 (New Position) | Filing History |
| 2024-06-06 8:37 pm Purchase | 2024-05-30 | 13D | Immatics N.V. IMTX | PERCEPTIVE ADVISORS LLC | 8,170,846 7.900% | 8,170,846 (New Position) | Filing History |
| 2024-05-13 5:06 pm Purchase | 2024-04-09 | 13G | Biodesix, Inc. BDSX | PERCEPTIVE ADVISORS LLC | 6,673,880 5.600% | 6,673,880 (New Position) | Filing History |
| 2024-05-01 4:57 pm Purchase | 2024-04-30 | 13D | Trinity Biotech plc TRIB | PERCEPTIVE ADVISORS LLC | 56,000,000 26.800% | 56,000,000 (New Position) | Filing History |
| 2024-04-17 4:16 pm Sale | 2024-04-16 | 13D | VBI VACCINES INC CDA COM VBIVQ | PERCEPTIVE ADVISORS LLC | 1,261,710 4.400% | -119,645 (-8.66%) | Filing History |
| 2024-04-17 4:15 pm Purchase | 2024-04-15 | 13D | Rhythm Pharmaceuticals, Inc. RYTM | PERCEPTIVE ADVISORS LLC | 5,143,575 8.300% | 1,874,996 (+57.36%) | Filing History |
| 2024-04-15 4:20 pm Purchase | 2024-04-09 | 13G | Contineum Therapeutics, Inc. Class A Common Stock CTNM | PERCEPTIVE ADVISORS LLC | 1,566,669 8.500% | 1,566,669 (New Position) | Filing History |
| 2024-04-15 08:21 am Purchase | 2024-04-11 | 13G | Acrivon Therapeutics, Inc. Common Stock ACRV | PERCEPTIVE ADVISORS LLC | 5,360,858 17.400% | 2,353,000 (+78.23%) | Filing History |
| 2024-04-10 4:50 pm Purchase | 2024-03-24 | 13D | Landos Biopharma, Inc. LABP | PERCEPTIVE ADVISORS LLC | 1,486,991 47.700% | 1,486,991 (New Position) | Filing History |
| 2024-04-03 6:18 pm Unchanged | 2024-04-01 | 13D | Rhythm Pharmaceuticals, Inc. RYTM | PERCEPTIVE ADVISORS LLC | 3,268,579 5.400% | 0 (Unchanged) | Filing History |
| 2024-03-20 5:51 pm Purchase | 2024-03-13 | 13D | Rhythm Pharmaceuticals, Inc. RYTM | PERCEPTIVE ADVISORS LLC | 3,268,579 5.400% | 8,566 (+0.26%) | Filing History |
| 2024-03-14 4:13 pm Purchase | 2024-03-05 | 13G | Precision BioSciences, Inc. DTIL | PERCEPTIVE ADVISORS LLC | 500,000 7.900% | 500,000 (New Position) | Filing History |
| 2024-03-11 5:45 pm Purchase | 2024-02-28 | 13G | Artivion, Inc. AORT | PERCEPTIVE ADVISORS LLC | 2,383,978 5.800% | 2,383,978 (New Position) | Filing History |
| 2024-03-06 4:15 pm Sale | 2022-12-31 | 13G | Relmada Therapeutics, Inc. RLMD | PERCEPTIVE ADVISORS LLC | 0 0.000% | -2,099,952 (Position Closed) | Filing History |
| 2024-03-01 8:05 pm Sale | 2023-05-24 | 13D | Crinetics Pharmaceuticals, Inc. CRNX | PERCEPTIVE ADVISORS LLC | 1,488,703 1.900% | -3,844,829 (-72.09%) | Filing History |